KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Accumulated Expenses: 2009-2024

Historic Accumulated Expenses for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $502.1 million.

  • Idexx Laboratories' Accumulated Expenses fell 4.34% to $488.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $488.9 million, marking a year-over-year decrease of 4.34%. This contributed to the annual value of $502.1 million for FY2024, which is 4.89% up from last year.
  • Per Idexx Laboratories' latest filing, its Accumulated Expenses stood at $502.1 million for FY2024, which was up 4.89% from $478.7 million recorded in FY2023.
  • Over the past 5 years, Idexx Laboratories' Accumulated Expenses peaked at $502.1 million during FY2024, and registered a low of $415.6 million during FY2020.
  • Over the past 3 years, Idexx Laboratories' median Accumulated Expenses value was $478.7 million (recorded in 2023), while the average stood at $471.5 million.
  • In the last 5 years, Idexx Laboratories' Accumulated Expenses climbed by 28.71% in 2020 and then decreased by 5.50% in 2022.
  • Idexx Laboratories' Accumulated Expenses (Yearly) stood at $415.6 million in 2020, then rose by 10.41% to $458.9 million in 2021, then declined by 5.50% to $433.7 million in 2022, then increased by 10.39% to $478.7 million in 2023, then grew by 4.89% to $502.1 million in 2024.